Design and synthesis of novel leucomycin analogues modified at the C-3 position. Part II: 3-O-(3-Aryl-2-propenyl)leucomycin analogues

Add time:07/18/2019    Source:sciencedirect.com

The design and synthesis of 16-membered macrolides modified at the C-3 position are described. Starting from fully protected intermediate (5), appropriate modifications including Heck reaction were performed to furnish 3-O-(3-aryl-2-propenyl)leucomycin A7 analogues (9a–9m). These leucomycin A7 derivatives showed improved in vitro antibacterial activities against clinically important pathogens including erythromycin-resistant Streptococcus pneumoniae (ERSP). SAR analysis of derivatives modified at the C-3 and C-3″ positions suggested that single modification at C-3 or C-3″ was effective for in vitro antibacterial activity.

We also recommend Trading Suppliers and Manufacturers of N-Methyl-N'-(2-propenyl)-1,2-hydrazinedicarbothioamide (cas 5638-74-4). Pls Click Website Link as below: cas 5638-74-4 suppliers

Prev:The synthesis and enzymic hydrolysis of (E)-2-[2,3-2H2]propenyl glucosinolate: Confirmation of the rearrangement of the thiohydroximate moiety
Next:Synthesis and antibacterial activities of 6-O-methylerythromycin A 9-O-(3-aryl-2-propenyl) oxime ketolide, 2,3-enol ether, and alkylide analogues)